ENTITY
Vertex Pharmaceuticals

Vertex Pharmaceuticals (VRTX US)

103
Analysis
Health Care • United States
Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatments. The Company develops drugs for the treatment of cystic fibrosis, autoimmune diseases, cancer, inflammatory bowel disease, and neurological disorders.
more
•05 Aug 2026 14:16

Primer: Vertex Pharmaceuticals (VRTX US) - Aug 2026

Vertex maintains an undisputed leadership position in the cystic fibrosis (CF) market, with its franchise, led by TRIKAFTA/KAFTRIO and the newly...

Logo
98 Views
Share
•23 Sep 2025 10:45

Primer: Vertex Pharmaceuticals (VRTX UW) - Sep 2025

Dominant Market Leader in Cystic Fibrosis: Vertex Pharmaceuticals commands the cystic fibrosis (CF) market with its portfolio of CFTR...

Logo
152 Views
Share
x